Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

2017 Medical Articles: Association Of Melanoma With Viagra And Cialis

November 2, 2017 By Law Offices of Thomas J. Lamb, P.A.

The five brand name erectile dysfunction (ED) drugs in the phosphodiesterase 5 (PDE-5) inhibitors class are Viagra (sildenafil), Cialis (tadalafil), Levitra (vardenafil), Staxyn (vardenafil), and Stendra (avanafil). Cialis is also prescribed sometimes when doctors see the signs and symptoms of benign prostatic hyperplasia (BPH). Two other … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Adcirca, Cialis, drug injury, drug side effects, Levitra, Melanoma, melanoma skin cancer, Revatio, Staxyn, Stendra, Viagra

Cialis, Levitra, And Viagra Might Cause Sudden Vision Loss Side Effect

August 29, 2017 By Law Offices of Thomas J. Lamb, P.A.

In August 2017 there is some additional information about the increased risk of developing the eye or vision side effect NAION which is included in a recent drug label change for Viagra, Cialis, and Levitra. As reported previously, the erectile dysfunction (ED) drugs Cialis (tadalafil), Levitra (vardenafil hydrochloride), and Viagra (sildenafil … [Read more...]

Filed Under: Unsafe Drugs Tagged With: blindness, Cialis, Levitra, Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), Viagra, vision loss

New Study Suggests Erectile Dysfunction Drugs May Not Cause Melanoma

May 30, 2017 By Law Offices of Thomas J. Lamb, P.A.

A recent study found in the Journal of the National Cancer Institute assessed the relationship between melanoma skin cancer and erectile dysfunction (ED) drugs like Viagra, Cialis, and Levitra.  Contrary to prior studies on this subject, they suggested that there may not be a link after all. This new study conducted a review of previous studies … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Adcirca, Cialis, drug injury lawsuits, erectile dysfunction drugs, Levitra, Melanoma, melanoma lawsuit, melanoma skin cancer, pde5, pde5 inhibitors, pde5i, Revatio, sildenafil, Staxyn, Stendra, tadalafil, vardenafil, Viagra

Viagra – Melanoma MDL Might Include Cialis Lawsuits And Levitra Cases

October 19, 2016 By Law Offices of Thomas J. Lamb, P.A.

As regards drug injury lawsuits concerning the melanoma side effect of male erectile dysfunction (ED) pills, that litigation began with Viagra cases being filed against Pfizer, the drug company responsible for Viagra. By April 2016 there was a sufficient federal court Viagra lawsuits filed that the Judicial Panel on Multidistrict Litigation (JPML) … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Cialis, Levitra, Melanoma, Viagra

Viagra, Nexium, And Invokana: Drug Injury Lawsuits Report: Summer 2016

August 9, 2016 By Law Offices of Thomas J. Lamb, P.A.

We are currently investigating possible drug injury lawsuits against the responsible pharmaceutical companies for patients who used the drugs listed below and developed certain side effects. (1) Erectile Dysfunction (ED) Pills, Benign Prostatic Hyperplasia (BPH) Medicines, and Pulmonary Arterial Hypertension (PAH) Medications in the … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Interstitial Nephritis, Acute Kidney Injury, Adcirca, Cialis, Farxiga, Glyxambi, Invokamet, Invokana, Jardiance, Ketoacidosis, Kidney Disease, Levitra, Melanoma, Revatio, Staxyn, Stendra, Synjardy, Viagra, Xigduo

Not Just Viagra: Cialis & Levitra also Linked to Melanoma Skin Cancer

July 19, 2016 By Law Offices of Thomas J. Lamb, P.A.

On June 30, 2016, the FDA announced that it would investigate the possible link between skin melanomas and erectile dysfunction (ED) drugs such as Viagra, Cialis, and Levitra. This recent announcement from the FDA Adverse Event Reporting System (FAERS) included all of the following PDE-5 inhibitors: Adcirca (tadalafil) Cialis … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Adcirca, Cialis, Levitra, Melanoma, Revatio, Staxyn, Stendra, Viagra

Viagra / Cialis / Levitra – Melanoma: July 2016 Medical / Legal Update

July 12, 2016 By Law Offices of Thomas J. Lamb, P.A.

The FDA is going to study a potential link between melanoma skin cancer and erectile dysfunction (ED) drugs such as Viagra, Cialis, and Levitra, according to information set forth in this document “January – March 2016: Potential Signals of Serious Risks/New Safety Information Identified from the FDA Adverse Event Reporting System (FAERS)”. In … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Adcirca, Cialis, Levitra, Melanoma, Revatio, Skin Cancer, Staxyn, Stendra, Viagra

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • PFAS Firefighter Gear Lawsuits
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.